DRI Hydrocodone Assay
- Primary DI
- 00884883000421
- Brand
- DRI Hydrocodone Assay
- Company
- Microgenics Corporation
- Model
- 10019766
- Published
- 2016-09-12
- Public version status
- Update
- Distribution status
- In Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
- Rx
- false
- OTC
- false
- Sterile
- false
- Single use
- true
Product Codes
| Code | Name |
|---|
| DJG | Enzyme Immunoassay, Opiates |
| LAS | Drug Specific Control Materials |
Product Code Classifications
| Code | Device | Specialty | Class |
|---|
| DJG | Enzyme Immunoassay, Opiates | Clinical Toxicology | 2 |
| LAS | Drug Specific Control Materials | Clinical Toxicology | 1 |
Identifiers And Packaging
| Identifier | Type | Agency | Package quantity | Status |
|---|
| 00884883000421 | Primary | GS1 | 0 | |
Alternate GTIN / UPC / EAN Codes
| Source identifier | GTIN-14 normalized | UPC-A | EAN-13 |
|---|
| 00884883000421 | 00884883000421 | 884883000421 | 0884883000421 |
GMDN Terms
| Term | Definition |
|---|
| Opiate/opiate metabolite IVD, kit, enzyme immunoassay (EIA) | A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of opiate and/or opiate metabolites in a clinical specimen, using an enzyme immunoassay (EIA) method. |
Regulatory Flags
- DUNS number
- 122153799
- Device count
- 1
- DM exempt
- false
- Premarket exempt
- false
- HCT/P
- false
- Kit
- false
- Combination product
- false
- Lot or batch
- true
- Serial number
- false
- Manufacturing date on label
- false
- Expiration date on label
- true
- Donation ID number
- false
- Contains natural rubber latex
- false
- No natural rubber latex
- false
- Sterilization required before use
- false
Other Devices From This Company
| Primary DI | Brand | Model | Catalog | Published |
|---|
| 00884883009301 | MAS Omni•IMMUNE Max, Level 1 | OIMM-101 | | 2025-08-12 |
| 00884883009318 | MAS Omni•IMMUNE Max, Level 2 | OIMM-202 | | 2025-08-12 |
| 00884883009325 | MAS Omni•IMMUNE Max, Level 3 | OIMM-303 | | 2025-08-12 |
| 00884883009332 | MAS Omni•IMMUNE Max, Sample Pack | OIMM-SP | | 2025-08-12 |
| 00884883009349 | MAS Omni•IMMUNE PRO Max, Level 1 | OPROM-101 | | 2025-08-12 |
| 00884883009356 | MAS Omni•IMMUNE PRO Max, Level 2 | OPROM-202 | | 2025-08-12 |
| 00884883009363 | MAS Omni•IMMUNE PRO Max, Level 3 | OPROM-303 | | 2025-08-12 |
| 00884883009370 | MAS Omni•IMMUNE PRO Max, Sample Pack | OPROM-SP | | 2025-08-12 |
| 00884883009257 | MAS OmniCORE Max, Level 1 | OCRM-101 | | 2025-06-27 |
| 00884883009264 | MAS OmniCORE Max, Level 2 | OCRM-202 | | 2025-06-27 |
| 00884883009271 | MAS OmniCORE Max, Level 3 | OCRM-303 | | 2025-06-27 |
| 00884883009288 | MAS OmniCORE Max, Sample Pack | OCRM-SP | | 2025-06-27 |
| 00884883009219 | MAS Omni-Core II Liquid Assayed Integrated Chemistry Control 1 | OCRL-101 | | 2025-01-31 |
| 00884883009226 | MAS Omni-Core II Liquid Assayed Integrated Chemistry Control 2 | OCRL-202 | | 2025-01-31 |
| 00884883009233 | MAS Omni-Core II Liquid Assayed Integrated Chemistry Control 3 | OCRL-303 | | 2025-01-31 |
| 00884883009240 | MAS Omni-Core II Liquid Assayed Integrated Chemistry Control Sample Pack | OCRL-SP | | 2025-01-31 |
| 00884883008830 | MAS Diabetes Max-SP (Sample-Pack) | B40000688 | | 2024-05-21 |
| 00884883008823 | MAS Diabetes Max, Multi-pack | B40000687 | | 2024-05-20 |
| 00884883006027 | Acrometrix BB NAT HBV Positive Control | 963603 | | 2022-10-07 |
| 00884883007376 | MAS omni Infectious BSI Positive Control Panel for use with Siemens Assays | 10027480-U | | 2021-11-03 |
Other Devices Sharing Product Codes
| Primary DI | Brand | Company | Product code | Published |
|---|
| 80810164510071 | Atida Fentanyl Drug of Abuse Test Rx | ACESO LABORATORIES INC. | DJG | 2026-03-23 |
| 10810173655979 | Healgen | Healgen Scientific Limited Liability Company | DJG | 2026-03-11 |
| 10810173655986 | Healgen | Healgen Scientific Limited Liability Company | DJG | 2026-03-11 |
| 10810173656037 | Healgen | Healgen Scientific Limited Liability Company | DJG | 2026-03-11 |
| B800DAU2V2ID5 | DRUGS OF ABUSE LEVEL 2 V2 | UTAK LABORATORIES, INC. | LAS | 2026-03-03 |
| B800DAUHIGHV43MLUIPM0 | DRUGS OF ABUSE HIGH V4 | UTAK LABORATORIES, INC. | LAS | 2026-02-25 |
| B800DAULOWV43MLUIPM5 | DRUGS OF ABUSE LOW V4 | UTAK LABORATORIES, INC. | LAS | 2026-02-25 |
| B800DAUMIDV43MLUIPM0 | DRUGS OF ABUSE MID V4 | UTAK LABORATORIES, INC. | LAS | 2026-02-25 |
| B800ETH177WBFOSBI5 | ETHANOL 76 MG/DL | UTAK LABORATORIES, INC. | LAS | 2026-02-23 |
| B800ETH76WBFOSBI5 | ETHANOL 76 MG/DL | UTAK LABORATORIES, INC. | LAS | 2026-02-23 |
| 00850076346027 | Healgen | HEALGEN LIFE SCIENCE, LLC | DJG | 2026-02-06 |
| B800ANTIF2SQD5 | ANTIFUNGALS LEVEL 2 | UTAK LABORATORIES, INC. | LAS | 2026-02-06 |
| B800ANLCCALMFFCCO5 | ANLC CAL | UTAK LABORATORIES, INC. | LAS | 2026-02-05 |
| B800CONTROL1V2SSH5 | MIXED CONTROL LEVEL 1 V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-05 |
| B800CONTROL2V2SSH0 | MIXED CONTROL LEVEL 2 V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-05 |
| B800DAUCONT1V2FRX5 | DAU CONTROL LEVEL 1 V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-05 |
| B800DAUCONT2V2FRX0 | DAU CONTROL LEVEL 2 V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-05 |
| B800EIACAL2V2UFRX5 | EIA CAL LEVEL 2 V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-05 |
| B800EIACALLEVEL1V25 | EIA CAL LEVEL 1 V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-05 |
| B800EIANEGV2UFRX5 | EIA NEG CAL V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-05 |
| B800MET1V2WBQD5 | METALS LEVEL 1 V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-02 |
| B800MET2V2WBQD5 | METALS LEVEL 2 V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-02 |
| B800MET3V2WBQD5 | METALS LEVEL 3 V2 | UTAK LABORATORIES, INC. | LAS | 2026-02-02 |
| 10810173655627 | Healgen | Healgen Scientific Limited Liability Company | DJG | 2026-01-30 |
| 10810173655740 | Healgen | Healgen Scientific Limited Liability Company | DJG | 2026-01-30 |
| B800ACETAHIGHV2UADX5 | ACETAMINOPHEN PLUS HIGH V2 | UTAK LABORATORIES, INC. | LAS | 2026-01-16 |
| B800ACETALOWV2UADX5 | ACETAMINOPHEN PLUS LOW V2 | UTAK LABORATORIES, INC. | LAS | 2026-01-16 |
| B800MOR225UKP5 | MORPHINE 225 NG/ML | UTAK LABORATORIES, INC. | LAS | 2026-01-16 |
| B800AMPH60V2WBCP5 | AMPH PLUS 60 NG/ML V2 | UTAK LABORATORIES, INC. | LAS | 2026-01-13 |
| B800DAUL3UFVMCI5 | DRUGS OF ABUSE LEVEL 3 | UTAK LABORATORIES, INC. | LAS | 2026-01-13 |